"The Diabetes Market Outlook to 2016"
The Diabetes Market Outlook to 2016 Published:May 2011 No.Of Pages:132 Price:US $ 3835 Introduction This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market-share data, sales forecasts and competitive landscape of the major players. The market size is forecast to 2016. Features and benefits * Quantify and assess the patient potential and treatment trends of diabetes globally. * Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive challenges. * Benchmark the leading anti-diabetic pipeline products under development and evaluate the evolution of the market in the forecast period. * Identify the leading players in the diabetes market and analyze their marketed portfolios, R&D pipelines and market strategies. * Evaluate the key market trends and growth strategies that holds potential for shaping the future diabetes market. Highlights Diabetes is the fifth leading cause of death in the developed countries. Diabetes prevalence is increasing at a fast pace in the developing countries due to lifestyle changes and a lack of awareness of its causes. This presents a huge opportunity to the marketers of diabetes products. The diabetes landscape is dynamic, with active R&D leading to the development of newer drug classes such as incretin mimetics, and regulatory agencies such as the FDA having increased the regulatory surveillance over diabetes drugs to avoid any “unacceptable” cardiovascular risk. Stringent regulatory screening in the light of increasing reports of serious adverse events of cardiovascular risk factors has had repercussions in terms of product withdrawal and has also delayed the launch of several late stage development products. Browse All Pharmaceuticals Market Research Reports Your key questions answered * What are the new therapy approaches in anti-diabetes market and which of these offer significant potential in the future? * What is the forecast commercial potential of the most promising compounds in clinical development? * Which products have been the major revenue generators in the market and what other categories are forecast to have commercial potential through 2016? * What are the current growth drivers in the global diabetes market shaping the future? * How will the patient population of diabetes sufferers change between 2010 and 2016? Table Of Contents Executive Summary Overview and patient potential of diabetes Global market analysis Pipeline analysis Competitive landscape About the author Disclaimer Overview and patient potential of diabetes Summary Introduction What is diabetes? Types of diabetes Type 2 diabetes Gestational diabetes mellitus Impaired glucose tolerance Diabetic complications Epidemiology Diagnosis How is diabetes measured? Treatment algorithm Global market analysis Summary Introduction Market analysis by country India China Key events/trends in the diabetes market Bydureon approved in the EU Eli Lilly and Boehringer Ingelheim’s collaborates over diabetes drug Novo Nordisk receives subpoena for three marketed products Newer agents recommended by NICE for diabetes treatment Amylin sues Lilly Market analysis by drug class Diabetes drug classes The insulin landscape Drugs targeting underlying causes of diabetes DPP-IV and GLP-1 differences Therapy area sales forecast Leading brands of the diabetes market Leading brands sales forecast Pipeline analysis Summary Introduction Emerging trends/key events in diabetes R&D Unmet need Inhaled insulin still a distant reality New approaches in diabetes R&D: magnesium, chromium, and vanadium Regulatory changes in the light of increasing cardiovascular adverse effects Profiles of key pipeline products Profiles of key molecules Pipeline sales forecast Competitive Landscape Summary Introduction Detailed analysis of the diabetes market players Novo Nordisk Sanofi Takeda Eli Lilly Merck & Co. Appendix Scope Market forecast Epidemiology forecast Glossary/Abbreviations Bibliography/References About Us: ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Follow us on Twitter: http://twitter.com/marketsreports Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689 Contact: Mr.Priyank 7557 Rambler road, Suite727,Dallas,TX75231 Tel: + 1 888 391 5441 E-mail: email@example.com http://www.reportsnreports.com Visit our Market Research Blog